News
Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.
United States Diabetes Drugs Market United States diabetes drugs market is expanding, driven by rising prevalence, biosimilar launches, sma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback